Insmed | Leverandørgjeld

Created with Highcharts 10.1.0Chart context menu


Trade Creditors Endring Dato
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Cytokinetics USD 20.37M 8.79M 2024-12
DBV Technologies USD 22.5M 2.68M 2024-09
Dynavax Technologies USD 9.06M 1.97M 2024-12
Gilead Sciences USD 833M 70M 2024-12
Insmed USD 77.21M 8.54M 2024-12
Novartis USD 4.57B 485M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Insmed Leverandørgjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.